Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...

Those eligible for Covid and flu jabs have been urged to start getting vaccinated as soon as possible to be protected.

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Sanofi and partner AstraZeneca have received approval from the U.S. Food and Drug Administration for a manufacturing line for ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...

RAPID CITY, S.D. - With fall approaching, not only will the days become darker and cooler, but cold and flu season will also ...